The U.S. Court of Federal Claims recently ruled against a petition for compensation under the National Vaccine Injury Compensation Program (VICP) in the case of Defenza v. Secretary of Health and Human Services (Docket No. 18-1601). The court upheld the decision of a Special Master who found that the petitioner, Stacy L. Defenza, did not provide sufficient evidence to prove that the flu vaccine caused her mother’s Guillain-Barre Syndrome (GBS). This ruling is significant as it highlights the challenges individuals face when seeking compensation for vaccine-related injuries.
The case centers around Linda L. Chervenok, who received a flu vaccination on October 21, 2015. Shortly after the vaccination, she began to experience severe symptoms, including shortness of breath and paralysis, and was diagnosed with GBS. Chervenok filed a petition for compensation in 2018, claiming that the vaccine caused her condition. However, she passed away in April 2025, and her daughter, Stacy L. Defenza, continued the case as the estate administrator.
The dispute arose when the Special Master, who initially reviewed the case, concluded that the evidence presented did not establish a causal link between the flu vaccine and the onset of GBS. The Special Master determined that the onset of symptoms occurring approximately 24 hours after vaccination was not sufficient to support the claim. Defenza challenged this decision, leading to the court's review.
Background of the Case
Linda L. Chervenok had a history of receiving flu vaccinations prior to the 2015 incident. On October 8, 2015, she underwent a procedure for chronic lower back pain, and two weeks later, she received the flu vaccine. Following the vaccination, her health deteriorated rapidly, leading to her GBS diagnosis.
In her petition, Chervenok claimed that the flu vaccine caused her GBS, supported by medical records and expert opinions. However, the respondent, the Secretary of Health and Human Services, argued that the onset of symptoms occurred too soon after vaccination to establish a causal relationship. The Special Master expressed skepticism about the claim and recommended that the petitioner consider withdrawing her petition.
The Ruling
The U.S. Court of Federal Claims, led by Judge Philip S. Hadji, upheld the Special Master’s decision. The court emphasized that the petitioner failed to meet the burden of proof required under the VICP. The ruling stated, "The onset of [Petitioner]’s GBS occurred too soon after vaccination to be causally related." The court found that the evidence presented did not sufficiently support the assertion that the flu vaccine caused the GBS.
The court acknowledged the complexities involved in establishing causation, particularly in cases where the onset of symptoms occurs shortly after vaccination. The Special Master had noted that while some epidemiological studies suggested a link between flu vaccines and GBS, they did not definitively establish that the vaccine caused the condition within the critical timeframe.
Impact of the Ruling
This ruling is significant for individuals seeking compensation for vaccine-related injuries, as it reinforces the stringent standards of proof required under the VICP. The court's decision illustrates the challenges petitioners face in establishing a causal link between vaccines and alleged injuries, particularly when the timing of symptom onset does not align with established medical understanding.
The ruling also serves as a reminder of the importance of presenting robust evidence, including expert opinions and scientific literature, when pursuing claims under the VICP. The court's reliance on the Special Master’s findings highlights the deference given to these initial determinations in vaccine injury cases.
What's Next
Defenza may have the option to appeal the court's decision, but details regarding any potential appeal were not available in the court filing. The outcome of this case could influence future claims under the VICP, as it underscores the necessity for clear and compelling evidence to support allegations of vaccine-related injuries.